BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30661770)

  • 21. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.
    Gbadegesin RA; Hall G; Adeyemo A; Hanke N; Tossidou I; Burchette J; Wu G; Homstad A; Sparks MA; Gomez J; Jiang R; Alonso A; Lavin P; Conlon P; Korstanje R; Stander MC; Shamsan G; Barua M; Spurney R; Singhal PC; Kopp JB; Haller H; Howell D; Pollak MR; Shaw AS; Schiffer M; Winn MP
    J Am Soc Nephrol; 2014 Sep; 25(9):1991-2002. PubMed ID: 24676636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel
    Hou L; Yin L; Wu Y; Zhao C; Du Y
    Front Pediatr; 2021; 9():732512. PubMed ID: 34858901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.
    Solanki AK; Widmeier E; Arif E; Sharma S; Daga A; Srivastava P; Kwon SH; Hugo H; Nakayama M; Mann N; Majmundar AJ; Tan W; Gee HY; Sadowski CE; Rinat C; Becker-Cohen R; Bergmann C; Rosen S; Somers M; Shril S; Huber TB; Mane S; Hildebrandt F; Nihalani D
    Kidney Int; 2019 Oct; 96(4):883-889. PubMed ID: 31472902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
    Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L
    Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
    Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
    Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
    Vivante A; Chacham OS; Shril S; Schreiber R; Mane SM; Pode-Shakked B; Soliman NA; Koneth I; Schiffer M; Anikster Y; Hildebrandt F
    Pediatr Nephrol; 2019 Sep; 34(9):1607-1613. PubMed ID: 31001663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects of CRB2 cause steroid-resistant nephrotic syndrome.
    Ebarasi L; Ashraf S; Bierzynska A; Gee HY; McCarthy HJ; Lovric S; Sadowski CE; Pabst W; Vega-Warner V; Fang H; Koziell A; Simpson MA; Dursun I; Serdaroglu E; Levy S; Saleem MA; Hildebrandt F; Majumdar A
    Am J Hum Genet; 2015 Jan; 96(1):153-61. PubMed ID: 25557779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model.
    Bierzynska A; Bull K; Miellet S; Dean P; Neal C; Colby E; McCarthy HJ; Hegde S; Sinha MD; Bugarin Diz C; Stirrups K; Megy K; Mapeta R; Penkett C; Marsh S; Forrester N; Afzal M; Stark H; BioResource N; Williams M; Welsh GI; Koziell AB; Hartley PS; Saleem MA
    Pediatr Nephrol; 2022 Nov; 37(11):2643-2656. PubMed ID: 35211795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
    Braun DA; Lovric S; Schapiro D; Schneider R; Marquez J; Asif M; Hussain MS; Daga A; Widmeier E; Rao J; Ashraf S; Tan W; Lusk CP; Kolb A; Jobst-Schwan T; Schmidt JM; Hoogstraten CA; Eddy K; Kitzler TM; Shril S; Moawia A; Schrage K; Khayyat AIA; Lawson JA; Gee HY; Warejko JK; Hermle T; Majmundar AJ; Hugo H; Budde B; Motameny S; Altmüller J; Noegel AA; Fathy HM; Gale DP; Waseem SS; Khan A; Kerecuk L; Hashmi S; Mohebbi N; Ettenger R; Serdaroğlu E; Alhasan KA; Hashem M; Goncalves S; Ariceta G; Ubetagoyena M; Antonin W; Baig SM; Alkuraya FS; Shen Q; Xu H; Antignac C; Lifton RP; Mane S; Nürnberg P; Khokha MK; Hildebrandt F
    J Clin Invest; 2018 Oct; 128(10):4313-4328. PubMed ID: 30179222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
    Liu J; Wang W
    Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
    Lovric S; Ashraf S; Tan W; Hildebrandt F
    Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in
    Zhao F; Zhu JY; Richman A; Fu Y; Huang W; Chen N; Pan X; Yi C; Ding X; Wang S; Wang P; Nie X; Huang J; Yang Y; Yu Z; Han Z
    J Am Soc Nephrol; 2019 May; 30(5):840-853. PubMed ID: 30910934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
    Bullich G; Trujillano D; Santín S; Ossowski S; Mendizábal S; Fraga G; Madrid Á; Ariceta G; Ballarín J; Torra R; Estivill X; Ars E
    Eur J Hum Genet; 2015 Sep; 23(9):1192-9. PubMed ID: 25407002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human nephrin Y
    Espiritu EB; Jiang H; Moreau-Marquis S; Sullivan M; Yan K; Beer Stolz D; Sampson MG; Hukriede NA; Swiatecka-Urban A
    J Biol Chem; 2019 Jul; 294(28):10773-10788. PubMed ID: 31152064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Bierzynska A; Soderquest K; Dean P; Colby E; Rollason R; Jones C; Inward CD; McCarthy HJ; Simpson MA; Lord GM; Williams M; Welsh GI; Koziell AB; Saleem MA; ;
    J Am Soc Nephrol; 2017 May; 28(5):1614-1621. PubMed ID: 27932480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics and WT1 genetic analysis of patients with steroid-resistant nephrotic syndrome accompanied with genitourinary malformations].
    Li JG; Zhao D; Ding J; Xiao HJ; Fan QF; Guan N; Chen Y; Zhang HW
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):692-7. PubMed ID: 19099861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.